Jinghua Pharmaceutical Group Co Ltd operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Jinghua Pharmaceutical Group Co Ltd with three other
pharmaceutical manufacturers in Asia:
of South Korea
sales of 139.44 billion Korean Won [US$124.10 million]
Shilpa Medicare Limited
(7.19 billion Indian Rupees [US$110.06 million]
of which 88%
was Bulk Drugs), and
Kolon Life Science Incorporation
based in South Korea
(158.28 billion Korean Won [US$140.87 million]
of which 45%
was Environment Material).
Jinghua Pharmaceutical Group Co Ltd reported sales of 881.32 million Chinese Renmimbi (US$127.97 million)
December of 2016.
increase of 13.0%
versus 2015, when the company's sales were 780.18 million Chinese Renmimbi.